Amgen sues Micro Labs over Sensipar generic

28-09-2016

Amgen sues Micro Labs over Sensipar generic

g0d4ather / Shutterstock.com

Amgen has filed a complaint against Indian drug company Micro Labs for allegedly infringing a patent centring on Sensipar (cinacalcet hydrochloride).


Amgen, Micro Labs, Sensipar, patent, ANDA, FDA, generic

LSIPR